Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]Florastamin PET/CT for Recurrent or Metastatic Prostate Cancer
NCT05936658Phase 3Active, not recruiting
- Sponsor
- FutureChem Co., Ltd.
- Start
- May 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 18f-florastamin in prostate cancer (PCa), sponsored by FutureChem Co., Ltd.. Started May 2023; status: active, not recruiting.
02
Drugs
18f-florastamin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05936658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05936658.